| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702360 | Surgical Oncology | 2017 | 10 Pages |
Abstract
These preclinical data indicate that SGM-101 is an attractive candidate for FGS of CEA-expressing tumors and is currently assessed in clinical trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Marian Gutowski, Bérénice Framery, Martin C. Boonstra, Véronique Garambois, François Quenet, Karen Dumas, François Scherninski, Françoise Cailler, Alexander L. Vahrmeijer, André Pèlegrin,